Verastem (VSTM) FCF Margin Growth (3y) (2021 - 2024)
Powered by 
Analysis
Verastem (VSTM) FCF Margin Growth (3y) (2021 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | -5,426.00 |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 9,545.00 |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 4,612.00 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -3,088.00 |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 14,060.00 |
| 10 | Verastem | 815.85 Mn | 679.49 Mn | 36.32 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 240,903.00 |
| Mar 31, 2022 | 157,805.00 |
| Dec 31, 2021 | -21,505.00 |
| Sep 30, 2021 | -54.12 Mn |
| Jun 30, 2021 | -257,659.00 |